Search for a command to run...
Promoter shareholding decreased by 6.03% YoY, while sector average remained stable at 0%.
Institutional ownership increased by 9.06% YoY, contrasting the sector's unchanged average, indicating selective interest in Gland Pharma.
Public participation fell by 4.95% YoY, aligning with overall selling trends in the sector, suggesting a lack of confidence among retail investors.
| Category | Trend | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter1 | 57.86% | 57.86% | 57.86% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | |
2Institution15 | 18.11% | 18.35% | 20.86% | 29.01% | 30.92% | 30.56% | 29.92% | 29.56% | |
3Public5 | 4.99% | 4.98% | 4.95% | 0.04% | 0.04% | 0.03% | - | 0.03% |